Skip to main content

IDENTIFICACION DE BIOMARCADORES DE RECAIDA EN CARCINOMAS DE ENDOMETRIO DE RIESGO CLINICO INTERMEDIO MEDIANTE ANALISIS MULTI-OMICO Y DE MICROAMBIENTE INMUNE

PI21/00920

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2021
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION INVESTIGACION BIOMEDICA HOSPITAL LA PAZ
Execution centre INSTITUTO DE INVESTIGACION HOSPITAL UNIVERSITARIO LA PAZ (IdiPAZ)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The Proteomic Landscape of CTNNB1 Mutated Low-Grade Early-Stage Endometrial Carcinomas

  • López-Janeiro, Álvaro
  • Brizzi, Emilia
  • Ruz-Caracuel, Ignacio
  • Alexandru, Raluca
  • Andrea, Carlos de
  • Berjón, Alberto
  • Yébenes, Laura
  • Mendiola, Marta
  • Heredia-Soto, Victoria
  • Montero-Calle, Ana
  • Barderas, Rodrigo
  • Ríos, Vivian de los
  • Redondo, Andrés
  • Peláez-García, Alberto
  • Hardisson, David
[Data Availability Statement] The mass spectrometry proteomics data have been deposited in the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD068004., Endometrial carcinoma is the most frequent gynecologic malignancy in western countries. In recent years, mutations in CTNNB1 have been associated with worse prognosis in low-risk carcinomas. However, there is a lack of understanding of the proteomic implications of CTNNB1 mutations in this type of tumor. In this study, we performed shotgun proteomics using Formalin-Fixed Paraffin-Embedded (FFPE) tissue samples of CTNNB1 mutated and wild-type low-risk endometrial carcinomas. A publicly available proteomic and transcriptomic database was used to validate results. Differential protein expression and Gene Set Enrichment Analysis revealed dysregulation of pathways associated with cell keratinization, immune response modulation, and intracellular calcium regulation. CTNNB1 mutated tumors showed immune dysregulation at multiple levels including cytokine secretion, cell adhesion, and lymphocyte activation. These results were supported by tissue multiplex immunofluorescence analysis, demonstrating reduced CD8 tumor-infiltrating lymphocytes and different immune spatial interaction patterns. Intracellular calcium dysfunction was associated with key transcript dysregulation. We found an increased expression of CAMK2A and ROR2, suggesting a potential role for non-canonical Wnt pathway activation in CTNNB1 mutated tumors., This research was funded by Instituto de Salud Carlos III (ISCIII) (PI21/00920), co-financed by the European Regional Development Fund “A way to achieve Europe” (FEDER)., Peer reviewed
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Weakly supervised deep learning to predict recurrence in low-grade endometrial cancer from multiplexed immunofluorescence images

  • Jiménez Sánchez, Daniel
  • López-Janeiro, Álvaro
  • Villalba-Esparza, María
  • Ariz Galilea, Mikel
  • Kadioglu, Ece
  • Masetto, Ivan
  • Goubert, Virginie
  • Lozano, María Dolores
  • Melero, Ignacio
  • Hardisson, David
  • Ortiz de Solórzano, Carlos
  • Andrea, Carlos de
Predicting recurrence in low-grade, early-stage endometrial cancer (EC) is both challenging and clinically relevant. We present a weakly-supervised deep learning framework, NaroNet, that can learn, without manual expert annotation, the complex tumor-immune interrelations at three levels: local phenotypes, cellular neighborhoods, and tissue areas. It uses multiplexed immunofluorescence for the simultaneous visualization and quantification of CD68 + macrophages, CD8 + T cells, FOXP3 + regulatory T cells, PD-L1/PD-1 protein expression, and tumor cells. We used 489 tumor cores from 250 patients to train a multilevel deep-learning model to predict tumor recurrence. Using a tenfold cross-validation strategy, our model achieved an area under the curve of 0.90 with a 95% confidence interval of 0.83–0.95. Our model predictions resulted in concordance for 96,8% of cases (κ = 0.88). This method could accurately assess the risk of recurrence in EC, outperforming current prognostic factors, including molecular subtyping., This work was supported by Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional (ISCIII and FEDER; grants PI21/01547—M.D.L. and C.E.A.; PI17/01723 and PI21/00920—A.L.-J and D.V.), and Fundació La Marató de TV3 (I.M., M.D.L., and C.E.A.). The funders had no role in study design, data collection and analysis, the decision to publish, or preparation of the paper. We would like to thank Raphaël Sandoz for technical support and troubleshooting.